Get the latest insights with syndromic testing webinars

Title: Multiplex versus low-plex testing for infectious illness – could you be underdiagnosing patients?

Speaker: Carmen Miravet Zaragoza, MSc Medical Science Liaison, Medical and Scientific Affairs, QIAGEN

Does low-plex PCR testing really contribute to the underdiagnosis of respiratory infections? And if so, by how much? Join Carmen Miravet as she presents a recent study comparing results from a theoretical low-plex viral respiratory assay with the multiplex QIAstat-Dx Respiratory SARS-CoV-2 Panel. She discusses how epidemiology analyses like this could help influence your diagnostic approach.

Title: Leveraging rapid multiplex testing during the height of respiratory season

Speaker: Anooj Shah, PharmD, MBA, BCIDP, Medical Science Liaison, Infectious Diseases, QIAGEN

Multiplex diagnostic testing increases opportunities for the detection of respiratory pathogens and can help avoid misdiagnosis due to overlapping clinical symptoms. By eliminating diagnostic uncertainty, these tests can help healthcare practitioners decide when to start or stop antimicrobial therapy with more confidence. Join Dr. Shah for this webinar as he walks through the benefits of multiplex diagnostic testing. He’ll focus on the unique benefits offered by the QIAstat-Dx multiplex diagnostic system, including real-time epidemiology tracking.

Title: Rapid multiplex PCR diagnosis for viral respiratory infections in patients with respiratory distress syndrome using an innovative higher-throughput instrument

Speaker: Pr. Jérôme Le Goff, Professor of Virology at the Medicine Faculty of Université Paris Cité Saint-Louis Hospital, Paris, France

Patients admitted to the ICU for respiratory distress syndrome have a higher risk of mechanical ventilation and death if they present with a viral infection at admission. Quickly detecting respiratory viruses in this patient population could help identify those at higher risk of complications. Join Pr. Jérôme Le Goff as he discusses a study from his hospital assessing the impact of using an automated multiplex PCR system, the QIAstat-Dx Rise, for patients admitted to the ICU for acute distress syndrome.

Title: Impact of antimicrobial stewardship intervention in conjunction with rapid multiplex respiratory diagnostics

Speaker: Eric Wenzler, PharmD, BCPS, BCIDP, AAHIVP, Department of Pharmacy Practice, University of Illinois, Chicago College of Pharmacy, USA

Quickly distinguishing between viral and bacterial causes of respiratory illness can lead to optimized antibacterial and antiviral use and assist with decisions on hospital admission and infection control. In this webinar, Dr. Wenzler explains how multiplex respiratory panels can enable quick and definitive pathogen identification to support antimicrobial stewardship efforts and optimize clinical and economic outcomes.

Title: Looking in the crystal ball: What will influenza-like illness season potentially look like post-COVID-19
pandemic?
Speaker: Roy F. Chemaly, MD, MPH, FACP, FIDSA, CMQ, MD Anderson Cancer Center, USA

The COVID-19 pandemic has dramatically changed the way influenza-like illnesses are diagnosed and managed. In addition, the seasonality of respiratory pathogens has shifted, making it difficult to predict future respiratory seasons. In this webinar, Dr. Roy F. Chemaly of MD Anderson Cancer Center discusses the impact of the pandemic on the incidence of respiratory viruses. He also explains how the diagnostic tools used to detect these viruses has evolved, and why a comprehensive diagnostic approach is crucial going forward, especially for immunocompromised patients.

Title: How is syndromic testing currently being used in the clinic and how will it impact diagnostics going forward?

Panel host: Davide Manissero, MD, MRCPCH, MSc, DTM&H, Chief Medical Officer, QIAGEN

Panel members: Stephan Gehring, Prof Dr Med, Children’s Hospital Universitätsmedizin Mainz, Germany Roy F. Chemaly, MD, MPH, FACP, FIDSA, CMQ, MD Anderson Cancer Center, USA Susan A. Weaver, PhD, CLS, Natividad Medical Center, USA

As SARS-CoV-2 approaches endemic status, it will become increasingly important to quickly distinguish COVID-19 from other influenza-like illnesses. Multiplex PCR panel tests can detect and differentiate multiple pathogens at once. But how are these tests currently being used in the clinic and how will they impact diagnostics going forward? In this panel discussion, join three experts in infectious diseases as they discuss their personal experiences using multiplex testing and address pressing questions about this diagnostic approach.

Title: Tackling COVID-19 through syndromic testing – QIAstat-Dx Respiratory SARS-CoV-2
Speaker: Davide Manissero, MD, MRCPCH, MSc, DTM&H, VP Head of Medical Affairs & Chief Medical Officer, Infection & Immune Diagnostics, QIAGEN

During this webinar, QIAGEN Chief Medical Officer Dr. Davide Manissero will discuss the role of multiplex respiratory PCR testing in the ongoing COVID-19 pandemic and how QIAGEN ramped up development efforts to be the first syndromic solution on the market. The importance of time to diagnosis and potential for co-infections as we approach the 2020-2021 influenza season will be discussed.

Title: A new multiplex syndromic system for respiratory diagnosis and improved patient care
Speaker: Dr. Steve Young, Director of Research and Clinical Trials, TriCore Reference Laboratories

This webinar discusses how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections. Acute respiratory tract infections are caused by a wide range of viral and bacterial pathogens and may share similar clinical presentations that make it difficult for physicians to diagnose based on symptoms alone. Syndromic testing with multiplex molecular panels offers clinical labs a way to quickly distinguish between a broad array of respiratory pathogens. In this webinar, Dr. Steve Young of Tricore Reference Laboratories presents a new technology for multiplexed respiratory testing in acutely ill patients. He shares data demonstrating the capabilities of syndromic respiratory testing as well as his impressions on the ease of doing comprehensive syndromic testing using the QIAstat-Dx Analyzer.